Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.

BACKGROUND: The liver is the most frequent site for metastases of colorectal cancer, which is the second largest contributor to cancer deaths in Europe. We did a randomised trial to compare an intrahepatic arterial (IHA) fluorouracil and folinic acid regimen with the standard intravenous de Gramont...

Full description

Bibliographic Details
Main Authors:	Kerr, D, McArdle, C, Ledermann, J, Taylor, I, Sherlock, D, Schlag, P, Buckels, J, Mayer, D, Cain, D, Stephens, R
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial.
by: Maughan, T, et al.
Published: (2003)

Hepatic artery chemotherapy and colorectal liver metastases - Reply
by: Kerr, D, et al.
Published: (2003)

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial.
by: Maughan, T, et al.
Published: (2002)

5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation.
by: Jebb, SA, et al.
Published: (1994)

The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy.
by: Grumett, SA, et al.
Published: (2001)

Scleroderma after 5-fluorouracil and folinic acid therapy in a patient with colon carcinoma
by: Didem Arslan TAŞ, et al.
Published: (2014-07-01)

Adjuvant chemoradiotherapy combined with cisplatin, 5-fluorouracil and folinic acid for locally advanced gastric cancer
by: Muharrem Kocar, et al.
Published: (2016-04-01)

Pharmacologic modulation of 5-fluorouracil by folinic acid and pyridoxine for treatment of patients with advanced breast carcinoma
by: David Machover, et al.
Published: (2022-05-01)

Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
by: Cals Laurent, et al.
Published: (2009-04-01)

A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases
by: Kobe Van Bael, et al.
Published: (2015-01-01)

Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment
by: Marloes Zoetemelk, et al.
Published: (2020-06-01)

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
by: Jun Gong, et al.
Published: (2022-09-01)

Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer
by: Stefan Peinert, et al.
Published: (2010-05-01)

Pharmacologic modulation of 5-fluorouracil by folinic acid and high-dose pyridoxine for treatment of patients with digestive tract carcinomas
by: David Machover, et al.
Published: (2021-06-01)

Ostwald-folin pipettes
by: 8096 British Standards Institution

MTHFR (C677T) polymorphism determination in patients with metastatic colon cancer and its effect on the treatment with 5-fluorouracil and folinic acid
by: Herrera Roberto, et al.
Published: (2007-02-01)

CETUXIMAB COMBINED WITH INFUSIONAL 5-FLUOROURACIL/FOLINIC ACID AND OXALIPLATIN IN METASTATIC COLORECTAL CANCER: POOLED ANALYSIS OF COIN AND OPUS STUDY DATA
by: Taieb, J, et al.
Published: (2012)

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer
by: Höhler Thomas, et al.
Published: (2004-07-01)

Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
by: Vincenzi B, et al.
Published: (2006-05-01)

A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium
by: Lise Verbruggen, et al.
Published: (2023-08-01)

A real-world analysis of nanoliposomal-irinotecan with 5-fluorouracil and folinic acid as third- or later-line therapy in patients with metastatic pancreatic adenocarcinoma
by: Jung Won Chun, et al.
Published: (2022-08-01)

Protein measurement with the folin phenol reagent /
by: Lowry, Oliver H.

Protein measurement with the folin phenol reagent /
by: Lowry, Oliver H.

Protein measurement with the folin phenol reagent*/
by: 194228 Lowry, Oliver H., et al.

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
by: Neoptolemos, J, et al.
Published: (2012)

Hepatic arterial chemotherapy: still on trial.
by: Kerr, D, et al.
Published: (2000)

Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
by: Se Jun Park, et al.
Published: (2021-11-01)

Combined effects of 5-Fluorouracil, Folinic acid and Oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy
by: De Vecchis Liana, et al.
Published: (2008-05-01)

Definitive liver radiotherapy for intrahepatic cholangiocarcinoma with extrahepatic metastases
by: Brian De, et al.
Published: (2023-03-01)

Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial
by: Shah, A, et al.
Published: (2021)

Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study
by: Masami Miki, et al.
Published: (2022-08-01)

Durable complete response in a patient with metastatic left‐sided colon cancer treated with 5‐fluorouracil, folinic acid, and irinotecan (FOLFIRI) and panitumumab: A case report
by: Esther Kim, et al.
Published: (2019-07-01)

Spectrophotometric determination of ajmaline and brucine by Folin Ciocalteu’s reagent
by: Singh Dhruv K., et al.
Published: (2003-01-01)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
by: Jaap D. Zindler, et al.
Published: (2017-07-01)

Application of the Folin-Ciocalteu method to the evaluation of Salvia sclarea extracts
by: Nataliia Hudz, et al.
Published: (2019-12-01)

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
by: Ingrid Garajová, et al.
Published: (2023-02-01)

Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases
by: Wei Liu, et al.
Published: (2023-06-01)

Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
by: Masatsugu Ishii, et al.
Published: (2022-01-01)

Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.
by: Gao Smith, F, et al.
Published: (2012)

FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
by: Xiaowei Zhang, et al.
Published: (2022-01-01)